Stocks and Investing
Stocks and Investing
Fri, October 15, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, October 14, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Berens Maintained (BGNE) at Buy with Decreased Target to $414 on, Oct 14th, 2021
Andrew Berens of SVB Leerink, Maintained "BeiGene, Ltd." (BGNE) at Buy with Decreased Target from $417 to $414 on, Oct 14th, 2021.
Andrew has made no other calls on BGNE in the last 4 months.
There are 2 other peers that have a rating on BGNE. Out of the 2 peers that are also analyzing BGNE, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Rebecca Liang of "Bernstein" Initiated at Buy and Held Target at $431 on, Tuesday, October 12th, 2021
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $407 on, Monday, August 16th, 2021
Contributing Sources